As c-Fos has been previously reported as a direct target of miR-101 in hepatoma cells (8), we only performed luciferase reporter assays to verify whether miR-101 regulated ERK2 expression by binding to its 3′-UTR. The gene discussed is MAPK1; the disease is hepatocellular carcinoma.